Both in Biotechnology
Solid Biosciences vs 4D Molecular Therapeutics
Over the past year SLDB returned +19.9% and FDMT returned +73.5%; their daily moves had a correlation of 0.53.
SLDB +19.9% FDMT +73.5%Growth of $1, one year, split-adjusted
| Metric | SLDB | FDMT |
|---|---|---|
| Price | $7.16 | $14.49 |
| Market cap | $767.7M | $800.5M |
| Today | −1.65% | −0.48% |
| 1 month | −26.7% | −1.2% |
| 6 months | +10.3% | +69.1% |
| Year to date | +27.0% | +93.2% |
| 1 year | +16.4% | +72.7% |
| Revenue growth (YoY) | — | +25106.7% |
| Gross margin | — | 100.0% |
| Net margin | — | −1929.0% |
| P/E (TTM) | — | — |
| Price / sales | — | 8.7× |
| Net cash | $377.7M | $341.7M |
| Dividend yield | — | — |
| Volatility (60d) | 59.6% | 68.4% |
| Short % of float | 22.4% | 27.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).